As a multifactorial disorder, the pathogenesis of OA involves mechanical stress, genetic predispositions, metabolic dysregulation, and biomechanical imbalances [3]
Nonclinical safety evaluation of a transforming growth factor receptor I kinase inhibitor in Fischer 344 rats and beagle dogs
Even with a high BMI, starting low is safer and gives the best chance for the patient to continue treatment
The adjusted Cox proportional hazards models were applied to assess the association of GLP-1 RAs with the risk of DR
To summarize the open-label extension of VESPER-1, berobenatide 2.4 mg weekly demonstrated 16% weight loss at 32 weeks, a favorable benefit-risk profile for monthly dosing, and safety and tolerability consistent with the class with no discontinuations related to gastrointestinal adverse events, and the gastrointestinal tolerability was excellent, said John B
Here's the sign up )